Showing 1 - 19 results of 19 for search 'Takanori Shibata', query time: 0.06s
Refine Results
-
1
Rh(III)-catalyzed directed C–H bond amidation of ferrocenes with isocyanates by Satoshi Takebayashi, Tsubasa Shizuno, Takashi Otani, Takanori Shibata
Published 2012-10-01
Article -
2
-
3
-
4
The effects of denosumab and alendronate on glucocorticoid-induced osteoporosis in patients with glomerular disease: A randomized, controlled trial. by Ken Iseri, Masayuki Iyoda, Makoto Watanabe, Kei Matsumoto, Daisuke Sanada, Takashi Inoue, Shohei Tachibana, Takanori Shibata
Published 2018-01-01
Article -
5
-
6
-
7
Development of a Flexible MEMS Sensor for Subsonic Flow by Koichi Murakami, Daiki Shiraishi, Shunsuke Mizumi, Yoshiko Oya, Naoto Omura, Takanori Shibata, Yoshiyasu Ichikawa, Masahiro Motosuke
Published 2022-08-01
Article -
8
Rapid regression of calciphylaxis in a hemodialysis patient after intensive management of disturbance of calcium and phosphate metabolism: a case report with literature review by Yuuki Mima, Yukihiro Wada, Yasuto Shikida, Toma Hamada, Nobuhiro Kanazawa, Ayana Iida, Motonori Sugiyama, Takanori Shibata
Published 2019-05-01
Article -
9
High fibroblast growth factor 23 levels are associated with decreased ferritin levels and increased intravenous iron doses in hemodialysis patients. by Hirokazu Honda, Tetsuo Michihata, Kanji Shishido, Keiko Takahashi, Go Takahashi, Nozomu Hosaka, Misa Ikeda, Daisuke Sanada, Takanori Shibata
Published 2017-01-01
Article -
10
A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schönlein purpura nephritis and IgA nephropathy. by Motonori Sugiyama, Yukihiro Wada, Nobuhiro Kanazawa, Shohei Tachibana, Taihei Suzuki, Kei Matsumoto, Masayuki Iyoda, Hirokazu Honda, Takanori Shibata
Published 2020-01-01
Article -
11
Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis. by Hirokazu Honda, Yasuna Kobayashi, Shoko Onuma, Keigo Shibagaki, Toshitaka Yuza, Keiichi Hirao, Toshinori Yamamoto, Naohisa Tomosugi, Takanori Shibata
Published 2016-01-01
Article -
12
Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy. by Yukihiro Wada, Kei Matsumoto, Taihei Suzuki, Tomohiro Saito, Nobuhiro Kanazawa, Shohei Tachibana, Ken Iseri, Motonori Sugiyama, Masayuki Iyoda, Takanori Shibata
Published 2018-01-01
Article -
13
Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous Nephropathy. by Kei Hihara, Masayuki Iyoda, Shohei Tachibana, Ken Iseri, Tomohiro Saito, Yasutaka Yamamoto, Taihei Suzuki, Yukihiro Wada, Kei Matsumoto, Takanori Shibata
Published 2016-01-01
Article -
14
Epidermal growth factor receptor inhibition with erlotinib partially prevents cisplatin-induced nephrotoxicity in rats. by Yukihiro Wada, Masayuki Iyoda, Kei Matsumoto, Yuki Shindo-Hirai, Yoshihiro Kuno, Yasutaka Yamamoto, Taihei Suzuki, Tomohiro Saito, Ken Iseri, Takanori Shibata
Published 2014-01-01
Article -
15
Intravenous phosphate loading increases fibroblast growth factor 23 in uremic rats. by Noriko Arai-Nunota, Masahide Mizobuchi, Hiroaki Ogata, Ai Yamazaki-Nakazawa, Chiaki Kumata, Fumiko Kondo, Nozomu Hosaka, Fumihiko Koiwa, Eriko Kinugasa, Takanori Shibata, Tadao Akizawa
Published 2014-01-01
Article -
16
Therapeutic effects of human mesenchymal stem cells in Wistar-Kyoto rats with anti-glomerular basement membrane glomerulonephritis. by Taihei Suzuki, Masayuki Iyoda, Takanori Shibata, Hirokazu Ohtaki, Kei Matsumoto, Yuki Shindo-Hirai, Yoshihiro Kuno, Yukihiro Wada, Yasutaka Yamamoto, Mio Kawaguchi, Seiji Shioda, Tadao Akizawa
Published 2013-01-01
Article -
17
Associations among apolipoproteins, oxidized high-density lipoprotein and cardiovascular events in patients on hemodialysis. by Hirokazu Honda, Tsutomu Hirano, Masashi Ueda, Shiho Kojima, Shinichi Mashiba, Yasuyuki Hayase, Tetsuo Michihata, Kanji Shishido, Keiko Takahashi, Nozomu Hosaka, Misa Ikeda, Daisuke Sanada, Takanori Shibata
Published 2017-01-01
Article -
18
Effect of Behavior Modification on Outcome in Early- to Moderate-Stage Chronic Kidney Disease: A Cluster-Randomized Trial. by Kunihiro Yamagata, Hirofumi Makino, Kunitoshi Iseki, Sadayoshi Ito, Kenjiro Kimura, Eiji Kusano, Takanori Shibata, Kimio Tomita, Ichiei Narita, Tomoya Nishino, Yoshihide Fujigaki, Tetsuya Mitarai, Tsuyoshi Watanabe, Takashi Wada, Teiji Nakamura, Seiichi Matsuo, Study Group for Frontier of Renal Outcome Modifications in Japan (FROM-J)
Published 2016-01-01
Article -
19
Effect of Renal Impairment on the Pharmacokinetics of Memantine by Takashi Moritoyo, Tomoko Hasunuma, Kazuhiro Harada, Tomonori Tateishi, Makoto Watanabe, Tsutomu Kotegawa, Masahiro Nagai, Yuji Kumagai, Tomomichi Fujitani, Takahumi Okura, Tomikazu Fukuoka, Kenichi Miyoshi, Bunzo Matsuura, Shinya Furukawa, Tomoe Kobori, Hiroyoko Moritoyo, Noriko Nishikawa, Tomoaki Tsujii, Hirotaka Iwaki, Masahiko Nakamura, Satoshi Makino, Kei Ohnuma, Koichiro Yuji, Megumi Hashimoto, Masaru Takasu, Yutaka Hashizume, Koji You, Tomoko Matsumura, Yuji Tanaka, Nahoko Matsumoto, Junichi Nakamura, Jun Miura, Tadao Akizawa, Kozo Kitazawa, Takanori Shibata, Aki Kuroki, Hirokazu Honda, Masanori Mukai, Kyoichi Ohashi, Takuya Morimoto, Hiromitsu Imai, Toshiaki Okudaira, Fuminori Sato, Junko Imanaga, Katsuhiro Tanaka, Masahiro Nomoto
Published 2012-01-01
Article